Latest filing published 25 Oct 2013 for Pure Bioscience, INC..
Insider track record
No signal scores available.
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +9.2%Entry US$27.36 · Close at T+365 US$29.88
- +459.1%Entry US$13.80 · Close at T+365 US$77.16
- +127.8%Entry US$23.28 · Close at T+365 US$53.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Peter C. Wulff: trading record in brief
Peter C. Wulff discloses dealings in 3 companies, chiefly Alphatec Holdings, Inc., Artes Medical Inc and Pure Bioscience, Inc. Over a trading history stretching from 26 November 2007 to 23 October 2013, the count stands at 11 filings.
On the market, this insider has only ever bought: 10 purchases, €76k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant.
A typical purchase (the median) is worth €6,612. After 5 purchases with a full 90-day history, the hit rate stands at 80% and the median 90-day move at +11.3%. This is a record of the past, not a forecast.
On 25 October 2013 came the latest disclosure, a share grant in Pure Bioscience, Inc. The last purchase on record was published on 12 August 2010, which is 5,932 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Peter C. Wulff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares0Common StockSEC:0001209191-13-049429:0
- 10,000 shares@ US$2.50Common StockSEC:0001181431-10-041604:0Canonical exit: 8 Nov 2010 (T+90)
- 2,300 shares@ US$1.25Common StockSEC:0001181431-09-014767:0Canonical exit: 4 Jun 2009 (T+90)
- 2,200 shares@ US$1.25Common StockSEC:0001181431-09-014767:1Canonical exit: 7 Jun 2009 (T+90)
- 3,000 shares@ US$3.50Common StockSEC:0001181431-08-062019:0Canonical exit: 5 Feb 2009 (T+90)
- 4,500 shares@ US$3.00Common StockSEC:0001181431-08-062019:1Canonical exit: 10 Feb 2009 (T+90)
- 100 shares@ US$2.19Common StockSEC:0001209191-07-066233:0Canonical exit: 24 Feb 2008 (T+90)
- 3,800 shares@ US$2.19Common StockSEC:0001209191-07-066233:1Canonical exit: 24 Feb 2008 (T+90)
- 1,100 shares@ US$2.20Common StockSEC:0001209191-07-066233:2Canonical exit: 24 Feb 2008 (T+90)
- 5,000 shares@ US$2.25Common StockSEC:0001209191-07-066233:3Canonical exit: 24 Feb 2008 (T+90)
10 of 10 declarations
